NCT04667442View on ClinicalTrials.gov

Investigational Performance Evaluation of the Nanomix eLab® COVID-19 Rapid Antigen Panel With Samples From COVID-19 Positive and Negative Human Subjects

CompletedOBSERVATIONAL
Enrollment

137

Participants

Timeline

Start Date

December 1, 2020

Primary Completion Date

December 14, 2021

Study Completion Date

December 14, 2021

Conditions
Covid19
Interventions
DIAGNOSTIC_TEST

Nanomix eLab® COVID-19 Rapid Antigen Panel (non-interventional)

COVID-19 Rapid Antigen Diagnostic Test

Trial Locations (1)

94608

Nanomix, Emeryville

Sponsors

Lead Sponsor

Nanomix
All Listed Sponsors
lead

Nanomix

INDUSTRY

NCT04667442 - Investigational Performance Evaluation of the Nanomix eLab® COVID-19 Rapid Antigen Panel With Samples From COVID-19 Positive and Negative Human Subjects | Biotech Hunter | Biotech Hunter